Adelphi partner, STELLA, has invested in seven new injection moulding machines of the latest generation for Q4 of 2023. This will help them be able to cater to a larger portfolio of customers along with increasing production for already existing clients with more machines expected early 2024. Also welcoming new toolmakers STELLA, has recruited a new team of trainees into their fold helping improve their team’s production and ability for expansion within the healthcare manufacturing industry. STELLA has been a key Adelphi’s partners since 2014, specialising in helping businesses develop their project from production, all the way through to sale of packaging materials. STELLA manufactures plastic components for the pharmaceutical and diagnostics sector exclusively using raw materials and pigments that have received approval for direct interaction with pharmaceuticals and food products, all in accordance with ISO 9001 standards.
|